Key Players: Cyprotex, Covance, GE Healthcare, SGS SA
The In Vitro Toxicology Testing Market by Toxicity Endpoint & Test, Technology, Method, Industry. In Vitro Toxicology Testing Market is expected to reach USD 8.74 billion by 2022 from an estimated USD 6.34 billion in 2017, at a CAGR of 6.6%.
The US is expected to hold the largest share of the global in vitro toxicology testing market in 2017, while China is expected to witness the highest growth during 2017 to 2022. Growing R&D investments in the biopharmaceutical sector, coupled with the rising number of CROs in this country contribute to the growth of this market in China.
Additionally, rising international pressure on Chinese cosmetics industry to ban animal testing is expected to further drive this market. Complete report on “In Vitro Toxicology Testing” spread across 253 pages, profiling 15+ companies and supported with 139 tables and 32 figures is now available at www.rnrmarketresearch.com/in-vitro…rket-report.html
The Ex vivo models segment is expected to grow at the highest CAGR during the forecast period.
Based on method, the in vitro toxicology testing market is segmented into cellular assays, biochemical assays, and ex vivo models. Ex vivo models segment is expected to grow at the highest CAGR during the forecast period owing to the growing adoption of these methods in the cosmetics industry as it is an effective alternative to animal testing for the toxicity testing of cosmetics and household products.
Objectives of the Study
- To define, describe, and forecast the global market by product & service, toxicity endpoint & test, technology, method, industry, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
Get Sample Copy Of this Report [email protected] www.rnrmarketresearch.com/contacts…mple?rname=607628
The major players in the global in vitro toxicology testing market include Cyprotex (An Evotec AG subsidiary, Germany), Covance (A Laboratory Corporations of America Holding’s subsidiary, US), Eurofins Scientific SE (Luxembourg), GE Healthcare (US), Thermo Fisher Scientific (US), SGS SA (Switzerland), Promega Corporation (US), Merck KGaA (Germany), Charles River Laboratories, Inc. (US), and Lonza Group Ltd. (Switzerland), among others.
- Drug manufacturers, cosmetic manufacturers, chemical industry, food industry,
- Academic and government research institutes
- Contract manufacturing organizations (CMOs) and contract research organizations (CROs)
- Venture capitalists and investors
Access “In Vitro Toxicology testing market” 2017-2022 Available at www.rnrmarketresearch.com/contacts…unt?rname=607628
Fundamental Key Point from Table of Content
In Vitro Toxicology Testing Market, By Product and Service:- Assays, Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-Based Elisa and Western Blots, Receptor-Binding Assays
In Vitro Toxicology Testing Market, By Toxicity Endpoints and Tests:- Introduction, ADME (Absorption, Distribution, Metabolism, and Excretion), Skin Irritation, Corrosion, and Sensitization, Genotoxicity Testing, Cytotoxicity Testing, Ocular Toxicity
In Vitro Toxicology Testing Market, By Technology:- Introduction, Cell Culture, Technologies, High-Throughput Technologies, Cellular Imaging Technologies
Access this Report @ www.rnrmarketresearch.com/contacts…hase?rname=607628
Category: Market Research Publishers and RetailersCompany about: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.